LFVN
NASDAQLifevantage Corporation
SectorHealth CareIndustryBiotechnology: Pharmaceutical Preparations
Price$6.08-0.14 (-2.33%)
01:30 PM07:45 PM
News · 26 weeks36-50%
2025-12-282026-06-21
Mix1690d
- Insider6(38%)
- Other3(19%)
- SEC Filings3(19%)
- Earnings2(13%)
- Leadership1(6%)
- Dividends1(6%)
Latest news
25 items- INSIDERDirector Lewis Darwin bought $6,059 worth of shares (705 units at $8.60), increasing direct ownership by 0.52% to 137,268 units (SEC Form 4)4 - Lifevantage Corp (0000849146) (Issuer)
- INSIDERDirector Beindorff Michael A sold $85,459 worth of shares (10,000 units at $8.55) (SEC Form 4)4 - Lifevantage Corp (0000849146) (Issuer)
- SECLifevantage Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Lifevantage Corp (0000849146) (Filer)
- SECSEC Form 10-Q filed by Lifevantage Corporation10-Q - Lifevantage Corp (0000849146) (Filer)
- PRLifeVantage Declares Quarterly DividendSALT LAKE CITY, May 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock, which will be paid June 15, 2026 to all stockholders of record at the close of business on June 1, 2026. About LifeVantage Corporation LifeVantage Corporation (NASDAQ:LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work
- PRLifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026SALT LAKE CITY, May 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2026. Third Quarter Fiscal 2026 Summary*: Revenue was $43.7 million, a decrease of 25.2% from the prior year period;Revenue in the Americas decreased 28.9%, and revenue in Asia/Pacific & Europe decreased 7.7%;Net income per diluted share was $0.11, versus $0.26 per diluted share a year ago;Adjusted earnings per diluted share was $0.12, compared to $0.26 a year ago; andAdjusted EBITDA was $3.2 million compa
- PRLifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026SALT LAKE CITY, April 22, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its third quarter ended March 31, 2026, after the stock market closes on Wednesday, May 6, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after
- PRLifeVantage Receives U.S. Patent for Healthy Glow Essentials StackSALT LAKE CITY, April 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced it has been granted a United States Patent No. 12,589,067 B2, issued March 31, 2026, for nutritional supplement composition and methods for activating cellular signaling genes of its Healthy Glow Essentials Stack™ which contains key activators Protandim® Nrf2 Synergizer® and TrueScience®Liquid Collagen.* According to the patent, compositions of the product duo improved the skin and impacted key regulatory genes associated with several important cellular pathways.
- PRLifeVantage Inspires with 'Breakthrough' Announcements at 2026 Momentum Academy in Las VegasSALT LAKE CITY, April 20, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, successfully concluded its three-day Momentum Academy event at Planet Hollywood Resort and Casino in Las Vegas, Nevada. Centered on the theme of "Breakthrough," the event brought together LifeVantage independent Consultants from across the country for an immersive experience focused on education, connection, and business growth. Attendees gained practical insights through leadership and product training, along with simple, actionable strategies to grow with greater clarity and con
- SECLifevantage Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Lifevantage Corp (0000849146) (Filer)
- PRLifeVantage Appointing Terrence Moorehead as Chief Executive OfficerSALT LAKE CITY, April 16, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) ("LifeVantage" or the "Company"), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Terrence Moorehead as the Company's new President and Chief Executive Officer and as a member of the Board of Directors (the "Board"), effective August 5, 2026. Mr. Moorehead is expected to commence employment with LifeVantage following the completion of his contractual commitments with his prior employer. Mr. Moorehead brings more than 25 years of leadership experience revitalizing brands, accelerating customer gr
- PRLifeVantage to Participate in Water Tower Research Insights Conference on Wednesday, April 15, 2026SALT LAKE CITY, April 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, Kristen Cunningham, Chief Sales Officer, and Lisa Barnes, Vice President Research & Development and Regulatory, will participate in the upcoming Water Tower Research Insights Conference on Wednesday, April 15, 2026. The webcast of the presentation will begin at approximately 12:30 p.m. Eastern Time on Wednesday, April 15, 2026. The event is open access for all investors and interested parties can register direc
- INSIDERSEC Form 4 filed by Cunningham Kristen4 - Lifevantage Corp (0000849146) (Issuer)
- INSIDERSEC Form 4 filed by Neufeld Alissa4 - Lifevantage Corp (0000849146) (Issuer)
- INSIDERSEC Form 4 filed by Aure Carl4 - Lifevantage Corp (0000849146) (Issuer)
- INSIDERSEC Form 4 filed by Fife Steven R4 - Lifevantage Corp (0000849146) (Issuer)
- SECSEC Form EFFECT filed by Lifevantage CorporationEFFECT - Lifevantage Corp (0000849146) (Filer)
- INSIDERSEC Form 4 filed by Lewis Darwin4 - Lifevantage Corp (0000849146) (Issuer)
- PRLifeVantage to Participate in the Sidoti Small Cap ConferenceSALT LAKE CITY, March 16, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the Sidoti Small Cap Conference, to be held March 18-19, 2026. Mr. Fife and Mr. Aure will meet virtually with investors and present at approximately 4:00 p.m. Eastern Time on Thursday, March 19, 2026. A live webcast of their presentation will be accessible on the News & Events section of the Company's Investor Relations website at https://lifevantage.gcs
- SECSEC Form S-3 filed by Lifevantage CorporationS-3 - Lifevantage Corp (0000849146) (Filer)
- INSIDERDirector Dayton Judd bought $152,422 worth of shares (33,197 units at $4.59), increasing direct ownership by 70% to 80,359 units (SEC Form 4)4 - Lifevantage Corp (0000849146) (Issuer)
- INSIDERDirector Lewis Darwin bought $20,651 worth of shares (3,955 units at $5.22), increasing direct ownership by 3% to 135,508 units (SEC Form 4)4 - Lifevantage Corp (0000849146) (Issuer)
- SECSEC Form 10-Q filed by Lifevantage Corporation10-Q - Lifevantage Corp (0000849146) (Filer)
- SECLifevantage Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits8-K - Lifevantage Corp (0000849146) (Filer)
- PRLifeVantage Declares Quarterly DividendSALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid March 16, 2026 to all stockholders of record at the close of business on March 2, 2026. About LifeVantage Corporation LifeVantage Corporation (NASDAQ:LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products w
LFVN FAQ
7 questionsWhat does Lifevantage Corporation do?
LifeVantage Corporation engages in the identification, research, development, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. The company offers Protandim, a line of scientifically-validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a...Where does LFVN stock trade?
Lifevantage Corporation (LFVN) is listed on NASDAQ.What sector and industry is LFVN in?
Lifevantage Corporation operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.Does LFVN pay a dividend?
LFVN's most recent ex-dividend date was 2026-06-01 with a cash dividend of $0.05 per share. No future ex-date is on file yet.What are analysts saying about LFVN?
Lifevantage Corporation has had 2 recent analyst actions on file. The most recent action was from Craig Hallum: Buy with a $3500.00 price target on 2025-01-14. Recent price targets range from $2600.00 to $3500.00.What companies are similar to LFVN?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare LFVN side-by-side with any of them on Quantisnow.How can I track LFVN on Quantisnow?
Quantisnow aggregates Lifevantage Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow LFVN to receive live email and push alerts on every new disclosure.